Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
31.82
+0.77 (2.48%)
Dec 20, 2024, 4:00 PM EST - Market closed
Avidity Biosciences Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$64.36
Upside
+102.26%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +126.27% | Dec 20, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $67 | Buy | Initiates | $67 | +110.56% | Nov 26, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $65 | Strong Buy | Maintains | $65 | +104.27% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +88.56% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +88.56% | Oct 31, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 → $65 | Strong Buy | Maintains | $60 → $65 | +104.27% | Oct 30, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $56 → $78 | Strong Buy | Maintains | $56 → $78 | +145.13% | Oct 21, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $59 | Strong Buy | Initiates | $59 | +85.42% | Sep 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $96 | Buy | Reiterates | $96 | +201.70% | Sep 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $96 | Buy | Reiterates | $96 | +201.70% | Sep 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $96 | Buy | Reiterates | $96 | +201.70% | Sep 9, 2024 |
| Barclays | Barclays | Buy Initiates $63 | Buy | Initiates | $63 | +97.99% | Aug 28, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $54 → $53 | Buy | Maintains | $54 → $53 | +66.56% | Aug 26, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +88.56% | Aug 13, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $45 → $54 | Buy | Maintains | $45 → $54 | +69.70% | Aug 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $45 → $60 | Strong Buy | Maintains | $45 → $60 | +88.56% | Aug 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.